Abstract
The present work was aimed to prepare, optimize and characterize nanostructured lipid carriers (NLCs) loaded with mechlorethamine for improvement in pharmacokinetics. Emulsification-ultrasonication method was used to formulate nanostructured lipid-based carriers. 3D-response surface methodology helped to explore the qualitative and quantitative relationship. Optimization was done by Box–Benhken design and response surface methodology using Stat–Ease design expert software. NLCs were spherical, non-aggregates with average size of 105.92 ± 1.04 nm and dispersity index 0.02; potential was around −30.1 ± 0.82 mV. The percentage entrapment efficiency and loading capacity of optimized NLCs was 91.7 ± 1.20% and 1.79 ± 0.11%, respectively. DSC revealed that the drug existed in amorphous form in NLCs. In-vitro cumulative percentage release study exhibited bi-phasic response. In case of NLCs; Tmax was achieved at 37.5 ± 0.56 min with a sharp increase in plasma level [Cmax value 0.62 ± 1.07 µg/ml]. The IC50 value was found to be 39.087 ± 0.13 and 21.39 ± 0.17 μM for pure mechlorethamine and NLCs, respectively. Nano-lipid carriers are prominent system for achieving delivery of cytotoxic nitrogen mustard drugs with improved therapeutic efficiency.
Correction Statement
This article has been republished with minor changes. These changes do not impact the academic content of the article.
Acknowledgments
The author acknowledges the facilities provided by the Shri Rawatpura Sarkar Institute of Pharmacy, Kumhari, Durg (C.G.). One of the authors, BG, is thankful to her supervisor for timely support and guidance throughout the study.
Disclosure statement
No potential conflict of interest was reported by the authors.